Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Standard Biotools Inc. (LAB)
Price$0.6855Cached quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85.3M | $91.0M | $106.3M | $97.9M | $130.6M | $138.1M | $117.2M | $113.0M | $101.9M | $104.4M | $114.7M | $116.5M | $71.2M | $52.3M | $42.9M | $33.6M | $25.4M |
| Gross profit | $42.5M | $44.9M | $50.5M | $37.1M | — | — | $64.3M | $61.6M | $52.0M | $58.4M | $114.4M | $116.2M | $70.9M | $52.0M | $42.8M | $22.0M | $13.9M |
| Gross margin | 49.86% | 49.32% | 47.44% | 37.83% | — | — | 54.83% | 54.57% | 50.99% | 55.95% | 99.74% | 99.74% | 99.58% | 99.43% | 99.77% | 65.49% | 54.80% |
| Research & development | $26.0M | $28.8M | $25.9M | $37.4M | $37.9M | $36.5M | $31.6M | $30.0M | $30.8M | $38.4M | $39.3M | $43.4M | $20.0M | $16.6M | $13.9M | $13.0M | $12.3M |
| Operating expenses | $152.8M | $172.4M | $127.0M | $153.3M | $198.0M | $189.2M | $169.1M | $161.1M | $160.3M | $177.6M | $164.9M | $168.3M | $89.8M | $70.4M | $61.4M | $48.1M | $43.4M |
| Operating income | −$110.2M | −$127.5M | −$76.6M | −$116.2M | −$67.5M | −$51.0M | −$51.8M | −$48.2M | −$58.4M | −$73.2M | −$50.2M | −$51.8M | −$18.7M | −$18.1M | −$18.6M | −$14.6M | −$18.0M |
| Operating margin | −129.20% | −140.08% | −72.03% | −118.64% | −51.66% | −36.94% | −44.22% | −42.64% | −57.25% | −70.07% | −43.72% | −44.51% | −26.20% | −34.53% | −43.31% | −43.42% | −70.98% |
| EBITDA | −$101.0M | −$115.0M | −$63.9M | −$103.8M | −$64.2M | −$47.0M | −$47.2M | −$42.8M | −$51.0M | −$66.5M | −$45.2M | −$47.8M | −$16.1M | −$15.9M | −$17.2M | −$13.4M | −$16.4M |
| EBITDA margin | −118.35% | −126.33% | −60.12% | −105.93% | −49.20% | −34.04% | −40.29% | −37.88% | −49.98% | −63.62% | −39.44% | −41.02% | −22.62% | −30.34% | −40.02% | −40.03% | −64.56% |
| Net income | −$74.9M | −$138.9M | −$74.7M | −$190.1M | −$59.2M | −$53.0M | −$64.8M | −$59.0M | −$60.5M | −$76.0M | −$53.3M | −$52.8M | −$16.5M | −$19.0M | −$22.5M | −$16.9M | −$19.1M |
| Net profit margin | −87.77% | −152.61% | −70.21% | −194.08% | −45.36% | −38.38% | −55.26% | −52.24% | −59.38% | −72.75% | −46.48% | −45.36% | −23.22% | −36.35% | −52.42% | −50.36% | −75.27% |
| Basic EPSper basic share | -$0.20 | -$0.52 | -$0.94 | -$2.43 | -$0.78 | -$0.74 | -$0.97 | -$1.49 | -$1.84 | -$2.62 | -$1.86 | -$1.90 | -$0.65 | -$0.86 | -$1.81 | -$8.94 | -$11.02 |
| Diluted EPSper diluted share | -$0.20 | -$0.52 | -$0.94 | -$2.43 | -$0.78 | -$0.74 | -$0.97 | -$1.49 | -$1.84 | -$2.62 | -$1.86 | -$1.90 | -$0.65 | -$0.86 | -$1.81 | -$8.94 | -$11.02 |
Owners
Reported shareholders
≈23.42%of listed shares
Casdin Eli91.84M shares · Jun 18, 2026
View holders
| Holder | % owned |
|---|---|
Casdin Eli | ≈23.42%91.84M shares |
Casdin Capital, LLC | 22.64%88.78M shares |
VIKING GLOBAL INVESTORS LP | 14.96%58.65M shares |
MAK CAPITAL ONE LLC | 7.35%28.81M shares |
Long Focus Capital Management, LLC | 5.99%23.5M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.12%12.25M shares |
BlackRock, Inc. | 2.11%8.25M shares |
Egholm Michael | ≈1.68%6.6M shares |
Hollow Brook Wealth Management LLC | 1.40%5.5M shares |
NEUBERGER BERMAN GROUP LLC | 1.26%4.96M shares |
Qube Research & Technologies Ltd | 1.23%4.82M shares |
ROYCE & ASSOCIATES LP | 1.15%4.53M shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.99%3.9M shares |
Tikvah Management LLC | 0.91%3.55M shares |
MILLENNIUM MANAGEMENT LLC | 0.90%3.51M shares |
MORGAN STANLEY | 0.72%2.83M shares |
D. E. Shaw & Co., Inc. | 0.72%2.82M shares |
Kim Hanjoon Alex | ≈0.70%2.76M shares |
JANE STREET GROUP, LLC | 0.64%2.51M shares |
Peapod Lane Capital LLC | 0.61%2.41M shares |
Percentages use 392.12M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 4, 2025Form 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC +7Director | BuyCommon Stock, $0.001 par value per share · indirect | 150.0K | $1.45 | $217.5K | 72.10M |
| Dec 3, 2025Form 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC +7Director | BuyCommon Stock, $0.001 par value per share · indirect | 75.0K | $1.44 | $108.0K | 71.95M |
| Dec 2, 2025Form 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC +7Director | BuyCommon Stock, $0.001 par value per share · indirect | 125.0K | $1.42 | $177.5K | 71.88M |
| Nov 25, 2025Form 4 | Casdin Partners GP, LLC +7Director,TenPercentOwner | BuyCommon Stock, $0.001 par value per share · indirect | 7.55M | $1.30 | $9.81M | 71.75M |
| Nov 24, 2025Form 4 | Casdin Partners GP, LLC +7Director,TenPercentOwner | BuyCommon Stock, $0.001 par value per share · indirect | 150.0K | $1.43 | $214.5K | 64.20M |